Doppler signals and bone erosions at enthesis indicate more severe PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Time to clinically meaningful response shorter with tofacitinib vs. placeboFebruary 23, 2022Psoriatic Arthritis
Psoriasis with concomitant psoriatic arthritis tied to an increased risk for endometriosisFebruary 23, 2022Psoriatic Arthritis
PsA: Secukinumab provides early and clinically meaningful improvements in patient-reported outcomesFebruary 23, 2022Psoriatic Arthritis
Patients are interrupting DMARD use well into the COVID-19 pandemicFebruary 17, 2022Psoriatic Arthritis
Severe Acute Systemic Reaction After the First Injections of IxekizumabFebruary 2, 2022Psoriatic Arthritis
A dermatologist-led model for CVD prevention in psoriasis may be feasibleFebruary 1, 2022Psoriatic Arthritis
More frequent secukinumab dosing found to benefit overweight psoriasis patientsJanuary 26, 2022Psoriatic Arthritis
